Herpes zoster

Med Clin North Am. 2013 Jul;97(4):503-22, ix. doi: 10.1016/j.mcna.2013.02.002. Epub 2013 Apr 17.

Abstract

Herpes zoster is a common condition that significantly affects health-related quality of life. Most cases occur in immunocompetent individuals older than 60 years; however, immunosuppressed patients are at particularly high risk. Post-herpetic neuralgia is the most common serious complication of herpes zoster, and is much more common in the very elderly. Vaccination with the zoster vaccine is recommended for most people older than 60, and reduces the incidence of herpes zoster and the occurrence of post-herpetic neuralgia.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Canada / epidemiology
  • Diagnosis, Differential
  • Herpes Zoster Vaccine
  • Herpes Zoster* / complications
  • Herpes Zoster* / diagnosis
  • Herpes Zoster* / epidemiology
  • Herpes Zoster* / therapy
  • Humans
  • Neuralgia, Postherpetic / etiology
  • Neuralgia, Postherpetic / therapy
  • Risk Factors
  • United States / epidemiology

Substances

  • Antiviral Agents
  • Herpes Zoster Vaccine